AGP Picks
View all

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on June 29, 2026

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
Low grip strength should not be used as an independent predictor of prostate cancer in older men
 The FIFA World Cup puts climate change on the global agenda
Pfeiffer Honored with ASM PRISM Award for Social Impact Excellence
Firan Technology Group Corporation (“FTG”) Announces Grand Opening of Its New FTG Aerospace Hyderabad Facility
Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results
Fortuna delivers robust Feasibility Study for the Diamba Sud Gold Project in Senegal: After-tax IRR of 60% and NPV5% of US$1 billion using US$3,500/oz
Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition
Minerals Technologies Inc. Files Plan of Reorganization in BMI OldCo Chapter 11 Cases to Comply with Court Deadline
Methanex Provides Update on Trinidad and Tobago Operations
FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH
Rayca Precision and Data Powered Therapeutics Partner to Advance AI-Designed Nanobody Cancer Therapeutics
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Rogers Communications 2Q26 Investment Community Teleconference July 22, 2026 at 8:00 a.m. ET
TMD Energy Limited Announces Financial Results for the Six Months Ended December 31, 2025
Beach Day API Launches Real-Time Beach and Ocean Data API for Developers
Elevra Lithium Breaks Ground on Fully Funded North American Lithium Expansion
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.